159
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Exploration of n-6 and n-3 Polyunsaturated Fatty Acids Metabolites Associated with Nutritional Levels in Patients with Severe Stable Chronic Obstructive Pulmonary Disease

, , , , , ORCID Icon, , , , & ORCID Icon show all
Pages 1633-1642 | Published online: 10 Jul 2020

References

  • ObeidatM, SadatsafaviM, SinDD. Precision health: treating the individual patient with chronic obstructive pulmonary disease. Med J Aust. 2019;210(9):424–428. doi:10.5694/mja2.5013830977152
  • DuffySP, CrinerGJ. Chronic obstructive pulmonary disease: evaluation and management. Med Clin North Am. 2019;103:453–461. doi:10.1016/j.mcna.2018.12.00530955513
  • RabeKF, HurdS, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. doi:10.1164/rccm.200703-456SO17507545
  • PizziniA, LungerL, SonnweberT, et al. The role of omega-3 fatty acids in the setting of coronary artery disease and COPD: a review. Nutrients. 2018;10(12):1864. doi:10.3390/nu10121864
  • MaltaisF, DecramerM, CasaburiR, et al. An official American thoracic society/european respiratory society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:e15–e62. doi:10.1164/rccm.201402-0373ST24787074
  • BarnesPJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi:10.1016/j.jaci.2016.05.01127373322
  • ItohM, TsujiT, NemotoK, et al. Undernutrition in patients with COPD and its treatment. Nutrients. 2013;5(4):1316–1335. doi:10.3390/nu504131623598440
  • HodsonM. Integrating nutrition into pathways for patients with COPD. Br J Community Nurs. 2016;21:548–552. doi:10.12968/bjcn.2016.21.11.54827809578
  • AknerG, CederholmT. Treatment of protein-energy malnutrition in chronic nonmalignant disorders. Am J Clin Nutr. 2001;74:6–24. doi:10.1093/ajcn/74.1.611451713
  • GarveyC, BaylesMP, HammLF, et al. Pulmonary rehabilitation exercise prescription in chronic obstructive pulmonary disease: review of selected guidelines: an official statement from the American association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:75–83. doi:10.1097/HCR.000000000000017126906147
  • IbrahimW, Harvey-DunstanTC, GreeningNJ. Rehabilitation in chronic respiratory diseases: in-hospital and post-exacerbation pulmonary rehabilitation. Respirology. 2019;24:889–898. doi:10.1111/resp.1351630835884
  • KimSH, ShinMJ, ShinYB, et al. Sarcopenia associated with chronic obstructive pulmonary disease. J Bone Metab. 2019;26:65–74. doi:10.11005/jbm.2019.26.2.6531223602
  • SpruitMA, WoutersEFM. Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases. Respirology. 2019;24:838–843. doi:10.1111/resp.1351230810256
  • MachadoA, QuadfliegK, OliveiraA, et al. Exercise training in patients with chronic respiratory diseases: are cardiovascular comorbidities and outcomes taken into account?-A systematic review. J Clin Med. 2019;8. doi:10.3390/jcm8091458
  • NiciL, ZuWallackR. Chronic obstructive pulmonary disease-evolving concepts in treatment: advances in pulmonary rehabilitation. Semin Respir Crit Care Med. 2015;36:567–574. doi:10.1055/s-0035-155561326238642
  • RochesterCL. Patient assessment and selection for pulmonary rehabilitation. Respirology. 2019;24:844–853. doi:10.1111/resp.1361631251443
  • DubeBP, LavenezianaP. Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD. J Thorac Dis. 2018;10:S1355–S1366. doi:10.21037/jtd.2018.02.2029928518
  • Gayan-RamirezG. Relevance of nutritional support and early rehabilitation in hospitalized patients with COPD. J Thorac Dis. 2018;10:S1400–S1414. doi:10.21037/jtd.2018.03.16729928522
  • SokolowskiCM, HigginsS, VishwanathanM, et al. The relationship between animal and plant protein intake and overall diet quality in young adults. Clin Nutr. 2019. doi:10.1016/j.clnu.2019.11.035
  • BordoniA, CapozziF. Foodomics for healthy nutrition. Curr Opin Clin Nutr Metab Care. 2014;17:418–424. doi:10.1097/MCO.000000000000008925010544
  • BaladyGJ, WilliamsMA, AdesPA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American heart association exercise, cardiac rehabilitation, and prevention committee, the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the American association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2007;27:121–129. doi:10.1097/01.HCR.0000270696.01635.aa17558191
  • SerkovaNJ, StandifordTJ, StringerKA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med. 2011;184:647–655. doi:10.1164/rccm.201103-0474CI21680948
  • CaiC, BianX, XueM, et al. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study. Int J Chron Obstruct Pulmon Dis. 2019;14:1769–1778. doi:10.2147/COPD.S20702331496676
  • KrishnanJK, MartinezFJ. Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps. Curr Opin Pulm Med. 2018;24:124–129. doi:10.1097/MCP.000000000000045629206658
  • Schrimpe-RutledgeAC, CodreanuSG, SherrodSD, et al. Untargeted metabolomics strategies-challenges and emerging directions. J Am Soc Mass Spectrom. 2016;27:1897–1905. doi:10.1007/s13361-016-1469-y27624161
  • O’CallaghanN, NoakesM. Meeting report from “frontiers in nutritional science: nutritional metabolomics”. Nutrients. 2014;6:3451–3459. doi:10.3390/nu609345125192025
  • DasUN. Ageing: is there a role for arachidonic acid and other bioactive lipids? A review. J Adv Res. 2018;11:67–79. doi:10.1016/j.jare.2018.02.00430034877
  • CalderPC, GrimbleRF. Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr. 2002;56(Suppl 3):S14–S19. doi:10.1038/sj.ejcn.160147812142955
  • YatesCM, CalderPC, RaingerG. Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther. 2014;141:272–282. doi:10.1016/j.pharmthera.2013.10.01024201219
  • CalderPC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45:1105–1115. doi:10.1042/BST2016047428900017
  • ChiltonFH, DuttaR, ReynoldsLM, et al. Precision nutrition and omega-3 polyunsaturated fatty acids: a case for personalized supplementation approaches for the prevention and management of human diseases. Nutrients. 2017;9(11):1165. doi:10.3390/nu9111165
  • InnesJK, CalderPC. Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2018;132:41–48. doi:10.1016/j.plefa.2018.03.00429610056
  • LemoineCM, BrighamEP, WooH, et al. Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD. BMC Pulm Med. 2019;19(1):97. doi:10.1186/s12890-019-0852-431122230
  • JohnsonM, McElhenneyWH, EgninM. Influence of green leafy vegetables in diets with an elevated omega-6: omega-3 fatty acid ratio on rat blood pressure, plasma lipids, antioxidant status and markers of inflammation. Nutrients. 2019;11(2):301. doi:10.3390/nu11020301
  • SimopoulosAP. An Increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8:128. doi:10.3390/nu803012826950145
  • FranzosaEA, Sirota-MadiA, Avila-PachecoJ, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293–305. doi:10.1038/s41564-018-0306-430531976
  • Pinto-PlataV, CasanovaC, DivoM, et al. Plasma metabolomics and clinical predictors of survival differences in COPD patients. Respir Res. 2019;20:219. doi:10.1186/s12931-019-1167-y31615518
  • CelliBR, DecramerM, WedzichaJA, et al. An official American thoracic society/european respiratory society statement: research questions in COPD. Eur Respir Rev. 2015;24:159–172. doi:10.1183/16000617.0000031526028628
  • HancuA. Nutritional status as a risk factor in COPD. Maedica (Buchar). 2019;14:140–143. doi:10.26574/maedica.2019.14.2.14031523295
  • GeaJ, BarreiroE. Nutritional abnormalities and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2019;23:531–532. doi:10.5588/ijtld.19.016031097058
  • OganN, AydemirY, EVT, et al. Diaphragmatic thickness in chronic obstructive lung disease and relationship with clinical severity parameters. Turk J Med Sci. 2019;49:1073–1078. doi:10.3906/sag-1901-16431293145
  • JungJW, YoonSW, LeeGE, et al. Poor nutritional intake is a dominant factor for weight loss in chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2019;23:631–637. doi:10.5588/ijtld.18.045631097074
  • AroraS, MadanK, MohanA, et al. Serum inflammatory markers and nutritional status in patients with stable chronic obstructive pulmonary disease. Lung India. 2019;36(5):393–398. doi:10.4103/lungindia.lungindia_494_1831464210
  • Paplinska-GorycaM, RubinsztajnR, Nejman-GryzP, et al. The association between serological features of chronic Chlamydia pneumoniae infection and markers of systemic inflammation and nutrition in COPD patients. Scand J Clin Lab Invest. 2017;77(8):644–650. doi:10.1080/00365513.2017.139369429069917
  • RussoGL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009;77:937–946. doi:10.1016/j.bcp.2008.10.02019022225
  • SainiRK, KeumYS. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - a review. Life Sci. 2018;203:255–267. doi:10.1016/j.lfs.2018.04.04929715470
  • RomanGC, JacksonRE, GadhiaR, et al. Mediterranean diet: the role of long-chain omega-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and alzheimer disease. Rev Neurol (Paris). 2019;175(10):724–741. doi:10.1016/j.neurol.2019.08.00531521398
  • WoodLG. Omega-3 polyunsaturated fatty acids and chronic obstructive pulmonary disease. Curr Opin Clin Nutr Metab Care. 2015;18:128–132. doi:10.1097/MCO.000000000000014225581034
  • VarrasoR, BarrRG, WillettWC, et al. Fish intake and risk of chronic obstructive pulmonary disease in 2 large US cohorts. Am J Clin Nutr. 2015;101:354–361. doi:10.3945/ajcn.114.09451625646333
  • CollinsPF, YangIA, ChangY-C, et al. Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update. J Thorac Dis. 2019;11(S17):S2230–S2237. doi:10.21037/jtd.2019.10.4131737350
  • SimopoulosAP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60:502–507. doi:10.1016/j.biopha.2006.07.08017045449
  • DuvallMG, LevyBD. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 2016;785:144–155. doi:10.1016/j.ejphar.2015.11.00126546247
  • AbdulnourRE, DalliJ, ColbyJK, et al. Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective. Proc Natl Acad Sci U S A. 2014;111:16526–16531. doi:10.1073/pnas.140712311125369934
  • RuttingS, PapanicolaouM, XenakiD, et al. Dietary omega-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD. Respir Res. 2018;19:211. doi:10.1186/s12931-018-0919-430390648
  • LeutiA, MaccarroneM, ChiurchiuV. Proresolving lipid mediators: endogenous modulators of oxidative stress. Oxid Med Cell Longev. 2019;2019:8107265. doi:10.1155/2019/810726531316721
  • LovewellRR, SassettiCM, VanderVenBC. Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection. Curr Opin Microbiol. 2016;29:30–36. doi:10.1016/j.mib.2015.10.00226544033
  • SharonG, CruzNJ, KangDW, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177:1600–1618 e1617. doi:10.1016/j.cell.2019.05.00431150625
  • ShiL, BruniusC, JohanssonI, et al. Plasma metabolites associated with healthy nordic dietary indexes and risk of type 2 diabetes-a nested case-control study in a Swedish population. Am J Clin Nutr. 2018;108:564–575. doi:10.1093/ajcn/nqy14530060042
  • ChengS, ShahSH, CorwinEJ, et al. Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement from the American heart association. Circ Cardiovasc Genet. 2017. doi:10.1161/HCG.0000000000000032